
Howard J. Rosen MD
Associate Professor, Neurology, UCSF School of Medicine
Join to View Full Profile
400 Parnassus AveSan Francisco, CA 94143
Phone+1 415-476-6880
Fax+1 415-476-4150
Are you Dr. Rosen?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Howard Rosen, MD is a board certified neurologist in San Francisco, California. He is currently licensed to practice medicine in California. He is an Associate Professor at UCSF School of Medicine.
Education & Training
- University of California (San Francisco)Residency, Neurology, 1993 - 1996
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1989 - 1992
- Boston University School of MedicineClass of 1989
Certifications & Licensure
- CA State Medical License 1993 - 2027
- CA State Medical License 1993 - 2027
- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- Reduced levels of angiogenesis biomarkers predict increased symptom severity in Chinese Americans with Alzheimer's disease with demographic-specific effect.Taylor P Johnson, Elena Tsoy, Jeffrey Shen, Will Rivera, Kevin Lieu
Neurocase. 2025-04-01 - 1 citationsDetection of Alzheimer Neuropathology in Alzheimer and Non-Alzheimer Clinical Syndromes With Blood-Based Biomarkers.Lawren VandeVrede, Hanna Cho, Mark Sanderson-Cimino, Fattin Wekselman, Yann Cobigo
JAMA Neurology. 2025-02-10 - Clinical and neuropathological associations of plasma Aβ/Aβ, p-tau217 and neurofilament light in sporadic frontotemporal dementia spectrum disorders.Binita Rajbanshi, Igor Prufer Q C Araujo, Lawren VandeVrede, Peter A Ljubenkov, Adam M Staffaroni
Alzheimer's & Dementia. 2025-01-29
Press Mentions
- This COVID-19 Practice: As the Pandemic Cancels Large in-Person Events, Neurology Conferences Go VirtualJune 12th, 2020
- NIH-Funded Research Consortium to Target Frontotemporal Lobar DegenerationOctober 16th, 2019
Grant Support
- Advancing Diagnosis of Dementia in Primary Care Practice(ADDPCP)UNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2029
- Advancing Diagnosis of Dementia in Primary Care Practice(ADDPCP)UNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2029
- Advancing Diagnosis of Dementia in Primary Care Practice(ADDPCP)UNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2029
- Frontotemporal Dementia: Genes, Images, and EmotionsUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2002–2028
- ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)MAYO CLINIC ROCHESTER2019–2025
- ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)MAYO CLINIC ROCHESTER2019–2025
- ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)MAYO CLINIC ROCHESTER2019–2025
- ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)MAYO CLINIC ROCHESTER2019–2025
- PREDICT-FTD: Multimodal Imaging Prediction of FTLD Subtypes.OHIO STATE UNIVERSITY2017–2025
- PREDICT-FTD: Multimodal Imaging Prediction of FTLD Subtypes.OHIO STATE UNIVERSITY2017–2025
- Multidisciplinary Research Fellowship in Alzheimer's disease and Related DementiasUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2005–2025
- Multidisciplinary Research Fellowship in Alzheimer's disease and Related DementiasUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2005–2025
- Multidisciplinary Research Fellowship in Alzheimer's disease and Related DementiasUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2005–2025